Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Reaches New 1-Year Low – Time to Sell?

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) reached a new 52-week low during trading on Thursday . The stock traded as low as $14.44 and last traded at $14.44, with a volume of 835 shares trading hands. The stock had previously closed at $15.40.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. UBS Group started coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a report on Friday, November 15th. They issued a “buy” rating and a $21.00 price objective for the company. William Blair raised Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research note on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.